These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25811429)

  • 21. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
    Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G
    Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. iRGD-coupled responsive fluorescent nanogel for targeted drug delivery.
    Su S; Wang H; Liu X; Wu Y; Nie G
    Biomaterials; 2013 Apr; 34(13):3523-33. PubMed ID: 23410678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery.
    Kang S; Lee S; Park S
    Polymers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in the tumor-penetrating peptide internalizing RGD for cancer treatment and diagnosis.
    Qian J; Zhou S; Lin P; Lei J; Zheng S; Xu W; Wang Y; Gao Z; Yang J
    Drug Dev Res; 2023 Jun; 84(4):654-670. PubMed ID: 36959702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-assembly of drug-loaded liposomes on genetically engineered target-recognizing M13 phage: a novel nanocarrier for targeted drug delivery.
    Ngweniform P; Abbineni G; Cao B; Mao C
    Small; 2009 Sep; 5(17):1963-9. PubMed ID: 19415651
    [No Abstract]   [Full Text] [Related]  

  • 26. Major effect of transcytosis on nano drug delivery to pancreatic cancer.
    Liu X; Jiang J; Nel AE; Meng H
    Mol Cell Oncol; 2017; 4(4):e1335273. PubMed ID: 28868347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of a proapoptotic peptide to intratumorally spreading cancer therapy.
    Chen R; Braun GB; Luo X; Sugahara KN; Teesalu T; Ruoslahti E
    Cancer Res; 2013 Feb; 73(4):1352-61. PubMed ID: 23248118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioengineered Protein Nanocage by Small Heat Shock Proteins Delivering mTERT siRNA for Enhanced Colorectal Cancer Suppression.
    Wang H; Liu N; Yang F; Hu N; Wang M; Cui M; Bruns N; Guan X
    ACS Appl Bio Mater; 2022 Mar; 5(3):1330-1340. PubMed ID: 35234441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting heat shock response pathways to treat pancreatic cancer.
    Xia Y; Rocchi P; Iovanna JL; Peng L
    Drug Discov Today; 2012 Jan; 17(1-2):35-43. PubMed ID: 21986108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics.
    Lee NK; Lee EJ; Kim S; Nam GH; Kih M; Hong Y; Jeong C; Yang Y; Byun Y; Kim IS
    J Control Release; 2017 Dec; 267():172-180. PubMed ID: 28821462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted drug delivery using iRGD peptide for solid cancer treatment.
    Liu X; Jiang J; Ji Y; Lu J; Chan R; Meng H
    Mol Syst Des Eng; 2017 Oct; 2(4):370-379. PubMed ID: 30498580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform.
    Moon H; Lee J; Min J; Kang S
    Biomacromolecules; 2014 Oct; 15(10):3794-801. PubMed ID: 25180761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
    Manjappa AS; Goel PN; Gude RP; Ramachandra Murthy RS
    J Drug Target; 2014 Sep; 22(8):698-711. PubMed ID: 24766186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
    Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
    Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles.
    Zhu Z; Xie C; Liu Q; Zhen X; Zheng X; Wu W; Li R; Ding Y; Jiang X; Liu B
    Biomaterials; 2011 Dec; 32(35):9525-35. PubMed ID: 21903260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
    Fukasawa M; Korc M
    Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.
    Wang Y; Saad M; Pakunlu RI; Khandare JJ; Garbuzenko OB; Vetcher AA; Soldatenkov VA; Pozharov VP; Minko T
    Clin Cancer Res; 2008 Jun; 14(11):3607-16. PubMed ID: 18519795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cyclophilin A on gene expression in human pancreatic cancer cells.
    Li M; Wang H; Li F; Fisher WE; Chen C; Yao Q
    Am J Surg; 2005 Nov; 190(5):739-45. PubMed ID: 16226951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoneedle-assisted delivery of site-selective peptide-functionalized DNA nanocages for targeting mitochondria and nuclei.
    Chan MS; Lo PK
    Small; 2014 Apr; 10(7):1255-60. PubMed ID: 24323905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-stimuli responsive gold nanocage-hyaluronic platform for targeted photothermal and chemotherapy.
    Wang Z; Chen Z; Liu Z; Shi P; Dong K; Ju E; Ren J; Qu X
    Biomaterials; 2014 Dec; 35(36):9678-88. PubMed ID: 25176062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.